Nascimento et al., 2012 - Google Patents
Analgesic effect of etoricoxib (Arcoxia®) 120 mg during retinal laser photocoagulationNascimento et al., 2012
View HTML- Document ID
- 16629072654558516803
- Author
- Nascimento V
- Primiano Jr H
- Maia Jr O
- Pelayes D
- Takahashi W
- Publication year
- Publication venue
- European Journal of Ophthalmology
External Links
Snippet
Purpose Panphotocoagulation reduces the risk of vision loss in proliferative diabetic retinopathy. However, not many patients tolerate this treatment well due to pain. Therefore, we evaluated the analgesic effect of etoricoxib during photocoagulation in patients with …
- 230000000649 photocoagulation 0 title abstract description 37
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Treister et al. | Risk factors for dupilumab-associated conjunctivitis in patients with atopic dermatitis | |
| Peterson et al. | COX-1–sparing NSAIDs—is the enthusiasm justified? | |
| Stafford et al. | National trends in antiobesity medication use | |
| Marwick | First antisense drug will treat CMV retinitis | |
| Cete et al. | A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department | |
| Mueller et al. | Warfarin dosing and body mass index | |
| Haller | Treatment of McArdle disease | |
| Madhusudan et al. | Antiangiogenic therapy for von Hippel-Lindau disease | |
| Jones et al. | Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery | |
| Chelliah et al. | Management of complex arteriovenous malformations using a novel combination therapeutic algorithm | |
| Milingou et al. | Alcohol intolerance and facial flushing in patients treated with topical tacrolimus | |
| Koller et al. | Atypical antipsychotic drugs and hyperglycemia in adolescents | |
| Serinken et al. | Topical Ketoprofen versus placebo in treatment of acute ankle sprain in the emergency department | |
| Sawyer et al. | Intramuscular ketorolac injections in the athlete | |
| West et al. | Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity | |
| Burgess et al. | Postoperative analgesia in enhanced recovery after surgery protocols: trends and updates | |
| Yadgari et al. | Is post-trabeculectomy serous choroidal detachment a risk factor for failure in the long term | |
| Uprichard | Management of rivaroxaban in relation to bodyweight and body mass index | |
| Cox et al. | Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users | |
| Ekman et al. | The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial | |
| Mutasim | Successful treatment of inflammatory linear verrucous epidermal nevus with tacrolimus and fluocinonide | |
| Nascimento et al. | Analgesic effect of etoricoxib (Arcoxia®) 120 mg during retinal laser photocoagulation | |
| Sampietro et al. | Null receptor homozygous familial hypercholesterolaemia: Quoad valetudinem long life treatment | |
| Goodarzi et al. | Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point? | |
| Marovt et al. | Apremilast monotherapy for palmoplantar pustulosis: Report of three cases |